Related Experiment Video

Updated: Mar 18, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

3.6K

Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy

Min Yan1,2, Chunli Wang3, Bin He1

  • 1State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China.

Medicinal Research Reviews
|July 14, 2016
PubMed

Insights

Aurora kinases are crucial for cell division and are implicated in cancer. Aurora kinase inhibitors (AKIs) are being developed as targeted cancer therapies, with ongoing research exploring their mechanisms and alternative inhibition strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • The Aurora kinase family (Aurora-A, -B, -C) are serine/threonine kinases.
  • Aurora-A and -B are key regulators of mitosis, while Aurora-C is involved in meiosis.
  • Aberrant Aurora kinase expression (overexpression, gene amplification) is linked to human malignancies, identifying them as oncogenes.

Purpose of the Study:

  • To review recent advances in Aurora-A kinase research and targeted cancer therapy.
  • To focus on the oncogenic roles and signaling pathways of Aurora-A in tumorigenesis.
  • To discuss preclinical and clinical data on Aurora kinase inhibitors (AKIs) and explore alternative inhibition strategies.

Main Methods:

  • Literature review of recent preclinical and clinical studies.
  • Analysis of oncogenic roles and signaling pathways of Aurora-A.
  • Evaluation of Aurora kinase inhibitor (AKI) data and alternative therapeutic approaches.

Main Results:

  • Aurora kinases are potent oncogenes driving tumorigenesis through specific signaling pathways.
  • Numerous Aurora kinase inhibitors (AKIs) have been developed, with some in clinical trials.
  • Novel functions of Aurora kinases in cancer and mechanisms of AKI action are emerging.

Conclusions:

  • Aurora kinases are validated targets for anticancer drug development.
  • Targeted inhibition of Aurora kinases holds promise for cancer treatment.
  • Further research into Aurora-A signaling and novel inhibition strategies is warranted.
Keywords:
Aurora kinase inhibitors (AKIs)Aurora-Amitosistargeted cancer therapytumorigenesis

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

895

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.4K